Actinobacteria are a major source of novel bioactive natural products. A challenge in the screening of 21 these microorganisms lies in finding the favorable growth conditions for secondary metabolite 22 production and dereplication of known molecules. Here, we report that Streptomyces sp. MBT27 23 produces 4-quinazolinone alkaloids in response to elevated levels of glycerol, whereby quinazolinones 24 A (1) and B (2) form a new sub-class of this interesting family of natural products. Global Natural 25
Introduction 39
Actinobacteria are a major source of bioactive compounds, producing some two third of all antibiotics 40 as well as molecules with a wide variety of activities such as anticancer, antifungal and 41 immunosuppressant [2, 4] . Traditionally, microbial natural product (NP) discovery has been done via 42 high-throughput screening followed by iterative bioassay-guided fractionation and structure 43 elucidation. While such pipelines were extremely successful and delivered a plethora of therapeutic 44 agents, in the modern era the large pharmaceutical companies move out of NP-discovery programs 45 due to high cost and chemical redundancy [1, 9, 28] . At the same time, the power of genome sequencing 46 brought the recognition that microorganisms harbor a vast and yet untapped biosynthetic potential, 47
and it rapidly became clear that the potential for metabolic diversity of even the best-studied model 48 organisms as producers of natural products had been grossly underestimated [3, 11, 18] . How could 49 these compounds have been missed by the very extensive HT screening campaigns of the 20th 50
century? The answer is that many of the biosynthetic gene clusters (BGCs) discovered by genome 51 mining are poorly expressed or cryptic under laboratory conditions [21, 27] . A drug-discovery pipeline 52 that is rapidly gaining momentum involves combining genome mining with fluctuating the culturing 53 conditions to achieve differential synthesis of NPs, followed by the metabolic profiling-based 54 identification of the bioactivity of interest [13, 46] . A major challenge thereby lies in finding the 55 appropriate chemical triggers or ecological cues to elicit the production of cryptic antibiotics (recently 56 reviewed in [33, 48, 49] ). The use of chemical elicitors is thereby a promising approach [10, 49] . 57
Manipulation of fermentation conditions for promising producer strains, known as the "one 58 strain many compounds" (OSMAC) approach, is an effective way of enhancing the production of 59 secondary metabolites [32, 5] . The regulatory networks that control the production of bacterial natural 60 products respond strongly to changes in carbon, nitrogen or phosphate concentration [40, 39] . The re-61 isolation of known metabolites is a major bottleneck in the discovery of new bioactive natural products. 62 A crucial step in this regard is the early identification of already known substances, in order to 63 concentrate the efforts on the discovery of new ones, a process known as dereplication [15] . Current 64 4 dereplication strategies include hyphenated techniques, such as LC-MS, LC-NMR, LC-NMR-MS, and LC-65 SPE-NMR. Bioactivity fingerprinting has also been used to dereplicate natural products based on their 66 biological modes of action [35] , while molecular networking is a powerful tool for the visualization and 67 dereplication of natural products [47, 44] . Mass spectrometry-based molecular networking relies on 68 clustering of molecules based on similarities in their MS/MS fragmentation patterns, which depends 69 on the structural features of the ionized molecules. The resulting clusters allow scientists to visually 70 explore the metabolites produced by a given strain under a specific growth condition, allowing rapid 71 dereplication of known compounds by automated spectral library searches, and to visualize their 72 unknown structural analogues [43] . 73
In this work we analyzed the potential of Streptomyces sp. MBT27 as producer of natural 74 products in response to changes in the carbon source. The strain had previously been identified as a 75
promising producer of NPs [50] . Extensive fluctuations in the secondary metabolite profiles were 76 observed depending on the carbon source used, and statistical methods combined with GNPS 77 molecular networking identified a family of known as well as novel quinazolinone compounds, in 78 response to high concentrations of glycerol. Quinazolinones are heterocyclic compounds with a wide 79 range of medical applications, such as antimicrobial, antiviral, antituberculosis and as enzyme 80 inhibitors (reviewed in [23, 16, 19] For the LC, solvent A was 95% H2O, 5% acetonitrile (ACN) and 0.1% formic acid; solvent B was 100% 112 ACN and 0.1% formic acid. The gradient used was 2% B for 1 min, 2-85% for 9 min, 85-100% for 1 min, 113 and 100% for 3 min. The flow rate used was 0.5 mL/min. As for the MS, the following ESI source 114 parameters were used: capillary voltage 3 kV, source temperature 325 °C, drying gas flow rate 10 115 L/min, and fragmentor 175 V. Full MS spectra were acquired in positive mode in the range of 100-116 6 1700 m/z, in the extended dynamic range mode. Internal reference masses of purine and Agilent HP-117 921 were continuously delivered to the ESI source through an Agilent 1260 isocratic pump. 118 Thermo Instruments MS system (LTQ Orbitrap XL, Bremen, Germany) equipped with an 119 electrospray ionization source (ESI) was used for LC-MS/MS analysis. The Waters Acquity UPLC system 120 equipped with Waters Acquity PDA was run using a SunFire Waters C18 column (3.5 µm, 100 Å, 4.6 × 121 150 mm), at a flow rate of 0.9 mL/min. Solvent A was 95% H2O, 5% acetonitrile (ACN) and 0.1% formic 122 acid; solvent B was 100% ACN and 0.1% formic acid. The gradient used was 2% B for 1 min, 2-85% for 123 15 min, 85-100% for 3 min, and 100% for 3 min. As for the MS, the following ESI parameters were 124 used: capillary voltage 5 V, spray voltage 3.5 kV, capillary temperature 300 °C, auxiliary gas flow rate with EtOAc, and the resulting crude extracts subjected to LC-MS analysis. Using the LC-MS data, a heat 216 map with added hierarchical clustering was generated, to visualize the production of different 217 metabolites under different culture conditions (Fig. 1) . Hierarchical clustering analysis of the LC-MS 218 data allows effective comparative analysis of metabolomics data, and the heat map revealed major 219 10 differences in the metabolic profiles of Streptomyces sp. MBT27, whereby different groups of 220 metabolites were enhanced depending on the carbon source used. Interestingly, not only the type of 221 carbon source, but especially also the concentration resulted in large changes in the metabolic profiles. 222
Doubling the concentration of either glycerol or glucose from 1% to 2% had a particularly profound 223 change on the metabolic profile. Thin layer chromatography (TLC) was conducted to compare 224 metabolic profiles of the 1% and 2% glycerol-grown cultures. Interestingly, this revealed that several 225 fluorescent compounds were differentially produced in the extracts of 2% glycerol-grown cultures 226 relative to those produced in 1% glycerol (Fig. 2a) . In order to provide statistical relevance to the data, 227 the metabolic profiles of 1% and 2% glycerol-grown cultures were compared using a volcano plot ( Fig.  228 2b). The volcano plot was then searched for the mass features which increased in production in 2% 229 glycerol as compared to 1%. A mass of m/z 281.1151 (1) stood out as its intensity had increased by 230 around 7000 fold (p-value = 0.002) in cultures fermented in 2% glycerol as compared to 1%. Besides known molecules, the network also contained many mass features that could not be 246 assigned to any of the previously identified metabolites. One of these was an ion with an m/z value of 247 281.1151 (1) , which was very highly increased in intensity (7000 fold, p-value = 0.002) when the 248 glycerol concentration was increased from 1% to 2%. It was closely connected (cosine score 0.91) to 249 another upregulated ion with an m/z value of 209.0932 (2), which was also not previously reported. 250
Both ions were part of the large spectral family comprising the annotated anthranilic acid (3), 251 anthranilamide (4), and the 4-quinazolinones 5 and 6, suggesting that they are structurally related 252 metabolites. The relationship between the increase in glycerol concentration and the strong increase 253 in the production of the compounds 1 and 2, was investigated further by expanding the range of 254 glycerol concentrations and analyzing the metabolic profiles. For this, Streptomyces sp. MBT27 was 255 cultured in glycerol concentrations ranging from 1-4% (w/v). ANOVA, followed by a post hoc Tukey's 256 HSD test, was performed to trace the variation in the production of 1 and 2 among the different 257 culturing conditions. A box plot was used to visualize such variation (Fig. S1 ). As observed earlier, the 258 production of 1 and 2 was significantly increased when the glycerol concentration was increased from 259 1% to 2%. However, further increase in glycerol concentration (3% and 4%), did not lead to any 260 significant increase in the production of 1 and 2. Accordingly, MM with 2% glycerol was used to culture 261 the bacteria, for the purpose of purification and identification of the new metabolites 1 and 2. 262 263
Isolation and structure elucidation of novel quinazolinones 264
To elucidate the structure of 1 and 2, upscale fermentation was done to obtain larger quantities of the 265 compounds. For this, Streptomyces sp. MBT27 was fermented in a total of 4 L of liquid MM 266 supplemented with 2% glycerol, and the supernatant was extracted with EtOAc. Following repeated 267 chromatographic isolation, compounds 1 and 2 were obtained as pure, colorless, amorphous powders. 268
Both compounds were fluorescent, showing UV absorption maxima at 224 and 322 nm and at 226 and 269 347 nm, respectively. The final structures of 1 and 2 were determined by the combination of NMR and 270 high resolution MS (Fig. 4) . 271
12
The high resolution mass of m/z 281.1151 for an [M + H] + established a molecular formula of 272 C13H16N2O5, with seven degrees of unsaturation, for 1 (yield 0.25 mg/L). The deduced molecular 273 formula was corroborated by the 13 C NMR attached proton test (APT) spectrum that exhibited 13 274 carbons in total. On the other hand, the 1 H NMR spectrum of 1 (Table 1) were part of a 1,4-dioxepane ring system, which was established based on the HMBC correlations 283 observed from H-1' to C-2 (C 79.0) and C-2' (C 64.6), from H-2' to C-1'' (C 65.7), and from H-1' to the 284 hemiacetal C-2'' (C 102.9). The remaining oxymethylene group CH2-3'' was connected to C-2'' based 285 on the HMBC correlations observed from H2-3'' to C-1'' and C-2''. The two substructures obtained 286 accounted for all of the oxygens and six out of the seven degrees of unsaturation required by the 287 molecular formula of 1. Accordingly, an additional ring including two nitrogen atoms was deduced to 288 connect the two substructures, forming a 4-quinazolinone ring. Consequently, compound 1 was 289 identified to be a di-glycerolated 4-quinozolinone, and was named quinazolinone A. 290
The [M + H] + molecular ion at m/z 209.0932 in the ESI-HRMS spectrum resulted in a molecular 291 formula of C10H12N2O3 for 2 (yield 0.3 mg/L). The 13 C NMR spectrum presented 10 signals, which was 292 consistent with the molecular formula ( Table 1) . The 1 H NMR spectrum of 2 resembled that of 1 in the 293 downfield aromatic region, and the major difference is the absence of a set of signals for the additional 294 glycerol unit. Further HMBC experiment confirmed 2 is a mono-glycerolated 4-quinazolinone (Fig. 5) . 
Biosynthesis of quinazolinones A and B 312
In our study, the production of 1 and 2 was dramatically enhanced in the cultures with 2% glycerol. 313
Elicitation by glycerol is an indication that glycerol may play a key role during their biosynthesis. The 314 aromatic ring system of quinazoline alkaloids is known to be derived from anthranilic acid, which in 315 turn is biosynthesized through the shikimate pathway [12] . In line with this, we propose that the 316 biosynthesis of the isolated quinazolinones starts from anthranilic acid, which is then converted to 317 anthranilamide (Fig. 6 ). Further successive attachments of two molecules of glycerol then results in 318 the formation of 2, followed by 1. However, multiple biosynthetic routes have been proposed for 319 quinazolinones, because the C-2 residue of the quinazoline ring may originate from various precursors. 320 
